Updated 2026-09-04 · NCT07745504See eligibility →
Treatment
Cagrilintide clinical trials
Active studies that list Cagrilintide as an intervention or treatment.
12active studies
7recruiting now
30countries represented
633largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-08-31 · NCT07253285See eligibility →
Updated 2026-06-25 · NCT07607587See eligibility →
Updated 2026-05-15 · NCT07557953See eligibility →
Updated 2026-05-07 · NCT07527195See eligibility →
Updated 2026-04-13 · NCT07411560See eligibility →
Recruiting nowPhase 1
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Updated 2025-07-25 · NCT07010432See eligibility →
Active, not recruitingPhase 3
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Updated 2026-09-04 · NCT07220759See eligibility →
Updated 2026-08-31 · NCT05669755See eligibility →
Active, not recruitingPhase 3
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Updated 2026-08-31 · NCT05567796See eligibility →
Active, not recruitingPhase 3
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
Updated 2026-08-06 · NCT07220642See eligibility →
Active, not recruitingPhase 3
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
Updated 2026-01-20 · NCT06780449See eligibility →
Related treatments
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.